Bio-Rad Laboratories, Inc. (BIO.B)
NYSE: BIO.B · Real-Time Price · USD
290.05
0.00 (0.00%)
Aug 1, 2025, 4:00 PM - Market closed
Smartsheet Market Cap
Bio-Rad Laboratories has a market cap or net worth of $7.51 billion as of August 1, 2025. Its market cap has decreased by -15.65% in one year.
Market Cap
7.51B
Enterprise Value
7.54B
1-Year Change
-15.65%
Ranking
Category
Stock Price
$290.05
Market Cap Chart
Since August 3, 2020, Bio-Rad Laboratories's market cap has decreased from $15.78B to $7.51B, a decrease of -52.41%. That is a compound annual growth rate of -13.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 7.75B | -15.75% |
| Dec 31, 2024 | 9.20B | -1.07% |
| Dec 29, 2023 | 9.30B | -25.52% |
| Dec 30, 2022 | 12.48B | -44.81% |
| Dec 31, 2021 | 22.62B | 30.09% |
| Dec 31, 2020 | 17.39B | 10.15% |
| Aug 3, 2020 | 15.78B | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.72B |
| Johnson & Johnson | 402.92B |
| AbbVie | 347.43B |
| AstraZeneca | 232.21B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 221.75B |
| UnitedHealth Group | 213.83B |
| Novo Nordisk | 211.90B |